ArfGAP with GTPase Domain, Ankyrin Repeat and PH Domain 3 (AGAP3) Peptide
AGAP3
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits AGAP3
- AGAP3 (ArfGAP with GTPase Domain, Ankyrin Repeat and PH Domain 3 (AGAP3))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- MRIP1 peptide corresponds to 13 amino acids of MRIP1.
-
-
- Indications d'application
- MRIP1 Peptide is used for blocking the activity of MRIP1 antibody . The MRIP1 antibody ships at 0.5 mg/mL and the MRIP1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- MRIP1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- AGAP3 (ArfGAP with GTPase Domain, Ankyrin Repeat and PH Domain 3 (AGAP3))
- Synonymes
- CENTG3 Peptide, AGAP-3 Peptide, CRAG Peptide, MRIP-1 Peptide, cnt-g3 Peptide, AV028425 Peptide, Centg3 Peptide, Crag Peptide, Crag. Peptide, ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 Peptide, AGAP3 Peptide, Agap3 Peptide
- ID gène
- 116988
- NCBI Accession
- NP_114152
- OMIM
- 110227613
- UniProt
- Q96P47
-
Vous êtes ici:
